Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $91.00 by Analysts at Barclays

Acadia Healthcare (NASDAQ:ACHCFree Report) had its price objective lowered by Barclays from $100.00 to $91.00 in a research report sent to investors on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock.

Several other analysts have also issued reports on ACHC. Royal Bank of Canada restated an outperform rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. UBS Group lifted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a buy rating in a research note on Wednesday, February 28th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a sell rating to a hold rating and set a $70.00 price objective for the company in a research note on Thursday, April 25th. Stephens upgraded shares of Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price target for the company in a report on Friday, January 5th. Finally, TD Cowen raised their price target on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an outperform rating in a report on Friday, March 1st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare has an average rating of Moderate Buy and a consensus target price of $88.89.

Check Out Our Latest Stock Report on Acadia Healthcare

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $66.12 on Thursday. The firm has a market capitalization of $6.11 billion, a PE ratio of -472.25, a price-to-earnings-growth ratio of 1.97 and a beta of 1.31. The company has a current ratio of 1.27, a quick ratio of 0.67 and a debt-to-equity ratio of 0.63. Acadia Healthcare has a 12 month low of $64.74 and a 12 month high of $87.77. The business’s 50-day moving average price is $76.77 and its 200-day moving average price is $77.52.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. During the same period last year, the business earned $0.75 earnings per share. The business’s quarterly revenue was up 9.1% on a year-over-year basis. Sell-side analysts forecast that Acadia Healthcare will post 3.56 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 2.00% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Acadia Healthcare

Several large investors have recently made changes to their positions in ACHC. Headlands Technologies LLC bought a new position in Acadia Healthcare during the third quarter valued at approximately $25,000. GAMMA Investing LLC purchased a new position in shares of Acadia Healthcare in the 4th quarter worth $26,000. Mather Group LLC. bought a new stake in shares of Acadia Healthcare in the first quarter worth $48,000. Fifth Third Bancorp increased its position in Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after acquiring an additional 136 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new position in Acadia Healthcare in the third quarter worth about $96,000.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Featured Stories

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with's FREE daily email newsletter.